This BIOtechNOW blog entry highlights a partnership formed by GlaxoSmithKline and Alnylam Pharmaceuticals to share intellectual property (IP) and industrial know-how to develop new therapies to treat the world’s most neglected tropical diseases. The IP Pool, originally formed in February 2009, will be managed by BIO Ventures for Global Health.
Read More...